XENETIC BIOSCIENCES, INC. Notes and Loans Payable, Current
XENETIC BIOSCIENCES, INC. (XBIO) had Notes and Loans Payable, Current of $212.81 thousand as of 2013-11-30, per its 10-Q filed 2014-01-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:NotesAndLoansPayableCurrent · last filed 2014-01-10
- 2013-11-30: Notes and Loans Payable, Current $212.81K.
- 2013-08-31: Notes and Loans Payable, Current $212.81K.
| Period end | Notes and Loans Payable, Current |
|---|---|
| 2013-11-30 | $212.81K 10-Q · filed 2014-01-10 |
| 2013-08-31 | $212.81K 10-Q · filed 2014-01-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |